Senior insider sale
Chief Financial Officer at TRANSMEDICS GROUP, INC. — senior position signals high conviction
$2.91M
21.93K shares
What this filing means
GORDON STEPHEN plans to sell 21.93K shares of TRANSMEDICS GROUP, INC. valued at approximately $2.91M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/29/2024ACC: 0001972362-24-000795
Officer· Chief Financial Officer
Since May 2019
21.93K
Shares to sell
$2.91M
Approx. market value
20K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
STOCK OPTION EXERCISE
COMPENSATION
5/29/2024
18KRESTRICTED STOCK
COMPENSATION
2/20/2024
2KTotal acquired20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/29/2024 | STOCK OPTION EXERCISE COMPENSATION | 18K | — |
2/20/2024 | RESTRICTED STOCK COMPENSATION | 2K | — |
| Total | 20K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.93K
Market value
$169.3K
3/8/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
20K
Market value
$2.74M
5/29/2024
Total
Units
21.93K
Value
$2.91M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/8/2024 | 1.93K | $169.3K | — | Completed |
| Planned — Approximate Date | ||||
5/29/2024 | 20K | $2.74M | NASDAQ | Planned |
| Total | 21.93K | $2.91M | ||